Tricopat

Tricopat The world's first device that stops hair fall and promote it's regrowth

Attending TRICO PERÚ 2026? Don’t miss this dedicated TRICOPAT Symposium.Join Dr. Gisela D’Atri for:“Innovación terapéuti...
05/08/2026

Attending TRICO PERÚ 2026?
Don’t miss this dedicated TRICOPAT Symposium.

Join Dr. Gisela D’Atri for:
“Innovación terapéutica en alopecias”
(Therapeutic innovation in alopecia)

📅 Friday, 14 August
🕛 12:15–13:00
📍 Delfines Hotel & Convention Center, Lima

And just a quick reminder: you can find us at booth P05 throughout the congress.

See you there.

Gray hair is one of the most recognizable signs of aging. In some people, however, it appears earlier than expected. Pre...
03/08/2026

Gray hair is one of the most recognizable signs of aging. In some people, however, it appears earlier than expected. Premature graying has been linked to stress, certain medical conditions, nutritional deficiencies and, less commonly, some medications [𝟭].

Why does hair lose its pigment? When, as a result of various internal or external factors, the pool of melanocyte stem cells (McSCs) in the hair follicle becomes depleted, or these cells lose their ability to self-renew and differentiate into functional melanocytes, melanin production decreases. Consequently, new hairs grow with reduced or absent pigment, giving them a gray appearance [𝟭–𝟮].

Plucking a gray hair does not make nearby hairs turn gray [𝟭]. The replacement hair from the same follicle will usually also lack pigment. Repeated plucking, however, can injure the follicle and may eventually lead to thinning or permanent hair loss [𝟯].

𝗥𝗲𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀:
[𝟭] Yedi Herdiana. Gray hair: from preventive to treatment. Clin Cosmet Investig Dermatol. 2025;18:1475–1494.
[𝟮] Jing Chen, Yixin Zheng, Chen Hu, Xuexiao Jin, Xiaoping Chen, Ying Xiao, Chaochen Wang. Hair graying regulators beyond hair follicle. Front Physiol. 2022;13:839859.
[𝟯] Bassukas ID, Hornstein OP. Effects of plucking on the anatomy of the anagen hair bulb: a light microscopic study. Arch Dermatol Res. 1989;281(3):188–192.

We’re excited to share that our next stop is Lima for TRICO PERÚ 2026.The congress will bring together dermatologists an...
31/07/2026

We’re excited to share that our next stop is Lima for TRICO PERÚ 2026.

The congress will bring together dermatologists and hair specialists for clinical discussions, practical workshops and live procedures.

We’ll be participating, so if you’re heading to Lima too, make sure to add these two TRICOPAT moments to your schedule:

📅 Friday, 14 August
🕛 12:15–13:00
Dedicated TRICOPAT Symposium: “Innovación terapéutica en alopecias” (“Therapeutic Innovation in Alopecia”) by Dr. Gisela D’Atri

📅 Saturday, 15 August
🕣 08:30–10:30
TRICOPAT featured as part of the congress’s Live Procedures session.

We are looking forward to meeting the Peruvian and international trichology community in this beautiful city and at such a wonderful venue!

📅 Congress: 14–15 August
📍 Delfines Hotel & Convention Center, Lima, Peru
📌 Booth P05

See you in Lima.

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧 𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: "𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗼𝗳 𝗵𝗮𝗶𝗿 𝘀𝗵𝗲𝗱𝗱𝗶𝗻𝗴 𝗮𝗺𝗼𝗻𝗴 𝘄𝗼𝗺𝗲𝗻"by Kovacevic, MD, derma...
27/07/2026

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧
𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: "𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗼𝗳 𝗵𝗮𝗶𝗿 𝘀𝗵𝗲𝗱𝗱𝗶𝗻𝗴 𝗮𝗺𝗼𝗻𝗴 𝘄𝗼𝗺𝗲𝗻"
by Kovacevic, MD, dermatovenerologist, Andy Goren, Jerry Shapiro, Rodney Sinclair, Neal M. Lonky, Mirna Situm, Vedrana Bulat, Željana Bolanča , and John McCoy.

Hair shedding patients are already sitting in your waiting room - even when they have attended for an unrelated condition. In a study of 300 women attending a public hospital for conditions other than alopecia, 40% of those without female pattern hair loss (104/263) reported excessive hair shedding on hair-washing days. Among women diagnosed with female pattern hair loss, the prevalence increased to 60% (21/37).

𝗧𝗵𝗲 𝗮𝗶𝗺 𝗼𝗳 𝘁𝗵𝗶𝘀 𝘀𝘁𝘂𝗱𝘆 𝘄𝗮𝘀 to assess the prevalence of self-reported excessive hair shedding among women attending a public hospital for conditions other than alopecia and to compare its prevalence between women with and without female pattern hair loss (FPHL). The study included 300 women who were interviewed by a dermatologist and evaluated for the presence or absence of FPHL. Participants self-assessed their hair shedding on hair-washing and non-hair-washing days using the Sinclair Hair Shedding Scale.

👉 𝗔 𝗺𝘂𝘀𝘁-𝗿𝗲𝗮𝗱: https://pmc.ncbi.nlm.nih.gov/articles/PMC6175177/

---
Excessive Hair Shedding; Female Pattern Hair Loss; FPHL; Sinclair Hair Shedding Scale; Dermatotrichology.

23/07/2026

In his latest column for Manila Bulletin, Philip Cu Unjieng takes readers inside the beginning of his own TRICOPAT journey under the care of Dr. Julieta Peralta-Arambulo.

Two sessions in, he writes openly about the consultation, the decision to choose a non-invasive approach and what the treatment feels like in practice.

There is no final reveal yet. It is a first-hand account of a process that has only just begun.

We look forward to following the next chapter.

Read “Here today, ‘hair’ tomorrow” in Manila Bulletin:
www.mb.com.ph/2026/07/19/here-today-hair-tomorrow

Hair extensions are widely used for cosmetic purposes, but they are not without risk. The main concern is traction alope...
17/07/2026

Hair extensions are widely used for cosmetic purposes, but they are not without risk. The main concern is traction alopecia, a form of hair loss caused by chronic mechanical tension on the hair shaft and follicle.

Tight or heavy extensions, particularly when worn continuously or repeatedly, increase the risk of follicular damage [1,2].

Early traction alopecia is usually reversible if the source of tension is removed promptly. However, prolonged traction may lead to permanent follicular damage and scarring hair loss [2,3].

The risk depends on factors such as the application technique, extension weight, duration of wear, and individual hair characteristics. Proper application, regular maintenance, and avoiding excessive tension can reduce, but not eliminate the risk [1,3].
References:
[1] Raechele Cochran Gathers, Michelle Jankowski, Melody Eide, Henry W Lim. Hair grooming practices and central centrifugal cicatricial alopecia. J Am Acad Dermatol. 2009;60(4):574-578.
[2] Khalifa E Sharquie, Robert A Schwartz, Wesal K Aljanabi, Camila K Janniger. Traction alopecia: clinical and cultural patterns. Indian J Dermatol. 2021;66(4):445.
[3] Aman Samrao, Vera H Price, Daniel Zedek, Paradi Mirmirani. The “fringe sign”: a useful clinical finding in traction alopecia. Dermatol Online J. 2011;17(11):1.

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧 𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: 𝗢𝗰𝗰𝗶𝗽𝗶𝘁𝗮𝗹 𝘀𝗵𝗼𝗿𝘁 𝗮𝗻𝗮𝗴𝗲𝗻 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲: 𝗘𝗽𝗶𝗱𝗲𝗺𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝘁𝗿𝗶...
16/07/2026

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧

𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: 𝗢𝗰𝗰𝗶𝗽𝗶𝘁𝗮𝗹 𝘀𝗵𝗼𝗿𝘁 𝗮𝗻𝗮𝗴𝗲𝗻 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲: 𝗘𝗽𝗶𝗱𝗲𝗺𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝘁𝗿𝗶𝗰𝗵𝗼𝘀𝗰𝗼𝗽𝘆 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀 𝗼𝗳 𝗮 𝗰𝗮𝘀𝗲 𝘀𝗲𝗿𝗶𝗲𝘀

by Flavia Oliveira Xavier de Brito, Rita Fernanda Cortez de Almeida, Carla Machado, Violeta Tortelly, Fernanda Torres, Professoressa Antonella Tosti , Michela Valeria Rita Starace, Prof. Lidia Rudnicka - Dermatology, Ncoza Dlova, Claudia Montoya Pellecapelli, Adriana Rakowska, Hoda Moneib, Alba Gómez-Zubiaur, Aline Blanco, Ana Lísia Giudice , Anna Waśkiel-Burnat , Colombina Vincenzi , Danielle Claudino Avelar, Federico Quadrelli , Gisela D'Atri, Leticia Arsie Contin, Lizet Rojano, Maria Andrea Ocampo, Mariana Lavia, Mariana AP , Maryanne Makredes Senna, Matilde Iorizzo, Natasha Atanaskova Mesinkovska, Ramon Grimalt , Sheila Requena-López, Taynara Barreto, Thaíssa Oliveira de Almeida Coelho, Bianca Maria Piraccini, Daniel Fernandes Melo.

𝗧𝗵𝗲 𝗮𝗶𝗺 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗿𝗲𝘁𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝘀𝘁𝘂𝗱𝘆 was to describe the epidemiological, clinical and trichoscopic features in a case series of patients with an occipital short anagen (OSA), an underrecognized localized phenotype of short anagen syndrome (SAS).

𝗖𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻: This case series describes a previously underrecognized localized phenotype of short anagen syndrome, limited to the central occipital scalp and predominantly affecting females. The clinical presentation, preserved hair texture, and absence of features suggesting hair fragility help distinguish it from acquired hair breakage. Recognition of this entity is important to avoid misdiagnosis and unnecessary treatments.

👉 𝗔 𝗺𝘂𝘀𝘁-𝗿𝗲𝗮𝗱: https://pubmed.ncbi.nlm.nih.gov/42312911/

---
Alopecia; Dermoscopy; Short Anagen Syndrome; Occipital Short Anagen

Rosemary oil has gained popularity as a natural option for hair loss, mainly following a randomized comparative trial su...
09/07/2026

Rosemary oil has gained popularity as a natural option for hair loss, mainly following a randomized comparative trial suggesting a similar improvement to 2% topical minoxidil after six months in patients with androgenetic alopecia [1].

However, this finding should be interpreted with caution. The study had important limitations, including a relatively small sample size and comparison with a lower-strength minoxidil formulation, rather than 5% preparation. Moreover, clinical data on rosemary oil in androgenetic alopecia remain limited, and the available evidence is not strong enough to place it on the same level as established hair loss treatments [1,2].

Topical minoxidil and oral finasteride remain among the best-studied evidence-based treatments for androgenetic alopecia, whereas rosemary oil should not be considered an evidence-equivalent substitute. Natural products may be considered by some patients who are reluctant to use conventional therapies, but rosemary oil should be regarded, at most, as a possible adjunctive option for selected individuals rather than a direct replacement for minoxidil [2,3].

It should also be remembered that rosemary essential oil and rosemary-derived ingredients may have irritant or sensitizing potential, particularly in susceptible individuals or depending on concentration and formulation [1,2].

References:
[1] Yunes Panahi, Mohsen Taghizadeh, Eisa Tahmasbpour Marzony, Amirhossein Sahebkar. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015;13(1):15–21.
[2] Aditya K Gupta, Mesbah Talukder, Mary A Bamimore. Natural products for male androgenetic alopecia. Dermatol Ther. 2022;35(4):e15323.
[3] Areej Adil, Marshall Godwin. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141.e5.

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧 𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: 𝗟𝗼𝗰𝗮𝗹𝗶𝘇𝗲𝗱 𝗹𝗶𝗰𝗵𝗲𝗻 𝗽𝗹𝗮𝗻𝗼𝗽𝗶𝗹𝗮𝗿𝗶𝘀 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗽𝗮𝘁𝗰𝗵𝗲𝘀: 𝗮 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗿𝗲𝘁𝗿𝗼...
07/07/2026

📚 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗯𝘆 𝗧𝗥𝗜𝗖𝗢𝗣𝗔𝗧

𝗔 𝘃𝗲𝗿𝘆 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: 𝗟𝗼𝗰𝗮𝗹𝗶𝘇𝗲𝗱 𝗹𝗶𝗰𝗵𝗲𝗻 𝗽𝗹𝗮𝗻𝗼𝗽𝗶𝗹𝗮𝗿𝗶𝘀 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗽𝗮𝘁𝗰𝗵𝗲𝘀: 𝗮 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗿𝗲𝘁𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝘀𝘁𝘂𝗱𝘆 𝗼𝗳 𝟳𝟰-𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀
by Claudia Montoya Pellecapelli , Maria Andrea Ocampo, Rita Fernanda Cortez de Almeida, André Luiz Vairo Donda, Michela Starace, Bianca Maria Piraccini, Gener Alejandro Mancilla, Prof. Lidia Rudnicka - Dermatology , Adriana Rakowska, Anna Waskiel-Burnat, Asmahane Souissi , Awatef Kelati, Kuzma Khobzei Khobzei Clinic , Tatiana Siliuk, Andrei Doroshkevich, Renan Minotto , Cecilia Navarro Tuculet, Maria Eugenia Cappetta, Luis Enrique Sánchez-Dueñas, Maria Julia Mojardin-Lopez, Mariana Lavia, Boris Sanchez, Daniela Lynett, Sebastian Augusto Mercau, Aldo Gálvez Canseco, David Saceda-Corralo, Carla Jorge Machado, Daniel Fernandes Melo.

𝗧𝗵𝗲 𝗮𝗶𝗺 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝗿𝗲𝘁𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝘀𝘁𝘂𝗱𝘆 was to describe epidemiological, clinical, trichoscopic, and histopathologic features of a localized non-patch form of LPP, based on clinical data from 74 patients.

𝗖𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻: This study pointed out that this condition may represent an early stage of classic or diffuse LPP. Finally, recognizing this presentation is crucial, as timely anti-inflammatory treatment may halt disease progression and scarring. Trichoscopy-guided biopsy of symptomatic yet non-alopecic areas can confirm diagnosis and guide intervention.

👉 𝗔 𝗺𝘂𝘀𝘁-𝗿𝗲𝗮𝗱: https://pubmed.ncbi.nlm.nih.gov/42314370/

---
Lichen planopilaris; Scarring alopecia; Cicatricial alopecia; Dermatotrichology; Hair disorders.

Hair thinning, hair loss, and changes in hair texture are common concerns during the menopausal transition and after men...
03/07/2026

Hair thinning, hair loss, and changes in hair texture are common concerns during the menopausal transition and after menopause. Studies show that up to 50% of women may experience these symptoms. They are primarily attributed to a decline in estrogen levels, as estradiol helps prolong the anagen phase of the hair cycle and supports hair growth.

However, the exact mechanisms are complex and may involve genetic predisposition, changes in the hair growth cycle, and increased sensitivity to androgens.

The aging process also reduces scalp metabolism and blood flow to hair follicles, potentially affecting the availability of vital nutrients. In addition to hormonal changes, other factors such as genetics, stress, diet, and the scalp microbiome condition may influence hair health [1,2].

Hair loss during menopause may manifest as diffuse thinning or widening of the parting. The most common diagnoses in these patients include female pattern hair loss (FPHL), frontal fibrosing alopecia (FFA) and telogen effluvium [1–3].

Menopause-related hair loss should not be considered irreversible by default. A thorough clinical evaluation is essential, as coexisting factors such as iron deficiency, thyroid disorders, nutritional deficiencies, or certain medications may contribute to hair loss and require specific treatment. Evidence-based treatments can often slow disease progression, reduce further hair loss, and improve hair density and quality of life [1–4].

References:
[1] Fabio Rinaldi, Anna Trink, Giorgia Mondadori, Giammaria Giuliani, Daniela Pinto. The menopausal transition: is the hair follicle “going through menopause”? Biomedicines. 2023;11(11):3041.
[2] Zouboulis CC, Blume-Peytavi U, Kosmadaki M, Roó E, Vexiau-Robert D, Kerob D, Goldstein SR. Skin, hair and beyond: the impact of menopause. Climacteric. 2022;25(5):434–442.
[3] Katie Roster, Lauren Fleshner, Turkan Banu Karatas, Anna Ecanow, Alyssa Sayegh, Banu Farabi, Shoshana Marmon. Menopause and common dermatoses: a systematic review. Am J Clin Dermatol. 2026;27(1):67–84.
[4] Stephano Cedirian, Francesca Pampaloni, Federico Quadrelli, Luca Rapparini, Francesca Bruni, Ginevra Martelli, Bianca Maria Piraccini, Michela Starace. Efficacy of skin patting and iontophoresis with dutasteride gel in male and menopausal female androgenetic alopecia: a pilot study. Dermatol Ther (Heidelb). 2025;15(11):3419–3424.

Address

Jakarta

Website

Alerts

Be the first to know and let us send you an email when Tricopat posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Tricopat:

Shortcuts

Share

Category